A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

NCT02436447 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal and Impaired Renal Function

Interventions

DRUG: MTP-131
DRUG: MTP-131
DRUG: MTP-131
DRUG: MTP-131

Sponsor

Stealth BioTherapeutics Inc.